Featured Research

from universities, journals, and other organizations

New Method Of Preserving Fertility In Young Women With Cancer

Date:
June 15, 2004
Source:
McGill University
Summary:
In a report recently published in the Lancet, physicians at the McGill University Health Centre (MUHC) have described a new way to preserve the fertility of women who must undergo chemotherapy. This method, which can be done quickly, does not involve surgery or hormonal stimulation of the ovaries.

Montreal, June 14, 2004 – In a report recently published in the Lancet, physicians at the McGill University Health Centre (MUHC) have described a new way to preserve the fertility of women who must undergo chemotherapy. This method, which can be done quickly, does not involve surgery or hormonal stimulation of the ovaries.

"Our technique of removing immature eggs from the woman's ovaries, then maturing them by a technique called in-vitro maturation (IVM), has been successfully used for eight female cancer patients," says MUHC Chief of Obstetrics and Gynecology and Director of the McGill University Reproductive Centre, Dr. Seang-Lin Tan. "We were able to immediately remove a number of healthy eggs without delaying chemotherapy."

The easiest technique of preserving fertility in young women with cancer is IVF and embryo freezing.

"However, this option is only available to adults with a partner," says Dr. Tan. "Additionally there is often inadequate time to undertake an IVF cycle before starting chemotherapy and the IVF fertility drugs should not be used for some cancers."

Another technique for preserving fertility involves removing a piece of the ovary, freezing and re-transplanting it after the patient finishes chemotherapy. However, this technique involves surgery and has not been very effective.

"Our technique does not involve hormone therapy or surgery. Women with cancer should be offered immature egg collection and egg or embryo freezing to preserve their fertility before they commence their cancer treatment," concludes Dr. Tan.


Story Source:

The above story is based on materials provided by McGill University. Note: Materials may be edited for content and length.


Cite This Page:

McGill University. "New Method Of Preserving Fertility In Young Women With Cancer." ScienceDaily. ScienceDaily, 15 June 2004. <www.sciencedaily.com/releases/2004/06/040615080909.htm>.
McGill University. (2004, June 15). New Method Of Preserving Fertility In Young Women With Cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2004/06/040615080909.htm
McGill University. "New Method Of Preserving Fertility In Young Women With Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/06/040615080909.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins